Corinna zur Bonsen-Thomas served as Abivax's Chair from August 2022 to May 2023 and has been an independent director since June 2017. Since April 2020 she has been Managing Director and Chief Executive Officer of RetInSight GmbH, an ophthalmic-imaging company she co-founded, and she was General Counsel of Smart Reporting GmbH from 2017 to 2022. From 1999 to 2015 she was a member of the Supervisory Board of Baxter AG (Austria). She has more than thirty years of international experience in the pharmaceutical, biopharmaceutical, medical and biotechnology industries. She received her First Law State Examination from Ludwig Maximilian University and her Second Law State Examination from the Bavarian Ministry of Justice. She is a member of the Audit Committee and the Nomination and Governance Committee.